Coplanar polychlorinated biphenyl-induced CYP1A1 is regulated through caveolae signaling in vascular endothelial cells

Chemico-Biological Interactions

Volumn 176, Issue 2-3, 2008, Pages 71-78

  Lim, Eun Jin ^a   Májková, Zuzana ^b   Xu, Shifen ^b   Bachas, Leonidas ^b   Arzuaga, Xabier ^a   Smart, Eric ^c   Tseng, Michael T ^d   Toborek, Michal ^c   Hennig, Bernhard ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d University of Louisville School of Medicine   (United States)

Author keywords

Aryl hydrocarbon receptor; Atherosclerosis; Caveolin 1; Endothelial cell activation; Persistent organic pollutants; Polychlorinated biphenyls

Indexed keywords

2,2',4,4',5,5' HEXACHLOROBIPHENYL; 3,3',4,4' TETRACHLOROBIPHENYL; 3,3',4,4',5 PENTACHLOROBIPHENYL; AROMATIC HYDROCARBON RECEPTOR; CAVEOLIN 1; CYTOCHROME P450 1A1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LYSATE; CELL MEMBRANE; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INDUCTION; FEMALE; INFLAMMATION; MALE; MOUSE; NONHUMAN; NULL ALLELE; OXIDATIVE STRESS; PATHOLOGY; RECEPTOR BINDING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VASCULAR DISEASE;

ANIMALS; CAVEOLAE; CAVEOLIN 1; CELLS, CULTURED; CYTOCHROME P-450 CYP1A1; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME INDUCTION; FEMALE; MALE; MICE; MICE, NUDE; OXIDATIVE STRESS; POLYCHLORINATED BIPHENYLS; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, LDL; SIGNAL TRANSDUCTION; TIME FACTORS;

MUS;

EID: 55249110374     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.08.007     Document Type: Article

References (47)

1. Hennig B., Reiterer G., Toborek M., Matveev S.V., Daugherty A., Smart E., and Robertson L.W. Dietary fat interacts with PCBs to induce changes in lipid metabolism in mice deficient in low-density lipoprotein receptor. Environ. Health Perspect. 113 (2005) 83-87
2. Toborek M., Barger S.W., Mattson M.P., Espandiari P., Robertson L.W., and Hennig B. Exposure to polychlorinated biphenyls causes endothelial cell dysfunction. J. Biochem. Toxicol. 10 (1995) 219-226
3. Hennig B., Slim R., Toborek M., and Robertson L.W. Linoleic acid amplifies polychlorinated biphenyl-mediated dysfunction of endothelial cells. J. Biochem. Mol. Toxicol. 13 (1999) 83-91
4. Stegeman J.J., Hahn M.E., Weisbrod R., Woodin B.R., Joy J.S., Najibi S., and Cohen R.A. Induction of cytochrome P4501A1 by aryl hydrocarbon receptor agonists in porcine aorta endothelial cells in culture and cytochrome P4501A1 activity in intact cells. Mol. Pharmacol. 47 (1995) 296-306
5. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
6. Hennig B., Toborek M., Ramadass P., Ludewig G., and Robertson L.W. Polychlorinated biphenyls, oxidative stress and diet. In: Preedy V.R., and Watson R.R. (Eds). Reviews in Food and Nutrition Toxicity (2005), CRC Press, Boca Raton, FL pp. 93-128
7. Safe S., and Krishnan V. Cellular and molecular biology of aryl hydrocarbon (Ah) receptor-mediated gene expression. Arch Toxicol. Suppl. 17 (1995) 99-115
8. Hennig B., Meerarani P., Slim R., Toborek M., Daugherty A., Silverstone A.E., and Robertson L.W. Proinflammatory properties of coplanar PCBs: in vitro and in vivo evidence. Toxicol. Appl. Pharmacol. 181 (2002) 174-183
9. Savouret J.F., Berdeaux A., and Casper R.F. The aryl hydrocarbon receptor and its xenobiotic ligands: a fundamental trigger for cardiovascular diseases. Nutr. Metab. Cardiovasc. Dis. 13 (2003) 104-113
10. Vogel C.F., Sciullo E., and Matsumura F. Activation of inflammatory mediators and potential role of ah-receptor ligands in foam cell formation. Cardiovasc. Toxicol. 4 (2004) 363-373
11. Sergeev A.V., and Carpenter D.O. Hospitalization rates for coronary heart disease in relation to residence near areas contaminated with persistent organic pollutants and other pollutants. Environ. Health Perspect. 113 (2005) 756-761
12. Li X.A., Everson W.V., and Smart E.J. Caveolae, lipid rafts, and vascular disease. Trends Cardiovasc. Med. 15 (2005) 92-96
13. Frank P.G., Lee H., Park D.S., Tandon N.N., Scherer P.E., and Lisanti M.P. Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 98-105
14. Matveev S., Li X., Everson W., and Smart E.J. The role of caveolae and caveolin in vesicle-dependent and vesicle-independent trafficking. Adv. Drug Deliv. Rev. 49 (2001) 237-250
15. Ring A., Le Lay S., Pohl J., Verkade P., and Stremmel W. Caveolin-1 is required for fatty acid translocase (FAT/CD36) localization and function at the plasma membrane of mouse embryonic fibroblasts. Biochim. Biophys. Acta 1761 (2006) 416-423
16. Smart E.J., Graf G.A., McNiven M.A., Sessa W.C., Engelman J.A., Scherer P.E., Okamoto T., and Lisanti M.P. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 19 (1999) 7289-7304
17. Pol A., Martin S., Fernandez M.A., Ferguson C., Carozzi A., Luetterforst R., Enrich C., and Parton R.G. Dynamic and regulated association of caveolin with lipid bodies: modulation of lipid body motility and function by a dominant negative mutant. Mol. Biol. Cell 15 (2004) 99-110
18. Frank P.G., Woodman S.E., Park D.S., and Lisanti M.P. Caveolin, caveolae, and endothelial cell function. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1161-1168
19. Hennig B., Shasby D.M., Fulton A.B., and Spector A.A. Exposure to free fatty acid increases the transfer of albumin across cultured endothelial monolayers. Arteriosclerosis 4 (1984) 489-497
20. Jensen A.A. Background levels in humans. In: Kimbrough R.D., and Jensen A.A. (Eds). Halogenated Biphenyls, Terphenyls, Naphthalenes, Dibenzodioxins, and Related Products (1989), Elsevier Science, Amsterdam 345-364
21. Arsenescu V., Arsenescu R.I., King V., Swanson H., and Cassis L.A. Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environ. Health Perspect. 116 (2008) 761-768
22. Song K.S., Li S., Okamoto T., Quilliam L.A., Sargiacomo M., and Lisanti M.P. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J. Biol. Chem. 271 (1996) 9690-9697
23. Tseng M.T., and Chang C.C. Ultrastructural localization of hippocampal TNF-alpha immunoreactive cells in rats following transient global ischemia. Brain Res. 833 (1999) 121-124
24. Sipka S., Eum S.Y., Son K.W., Xu S., Gavalas V.G., Hennig B., and Toborek M. Oral administration of PCBs induces proinflammatory and prometastatic response. Environ. Toxicol. Pharmacol. 25 (2008) 251-259
25. Feron O., Saldana F., Michel J.B., and Michel T. The endothelial nitric-oxide synthase-caveolin regulatory cycle. J. Biol. Chem. 273 (1998) 3125-3128
26. Repetto S., Salani B., Maggi D., and Cordera R. Insulin and IGF-I phosphorylate eNOS in HUVECs by a caveolin-1 dependent mechanism. Biochem. Biophys. Res. Commun. 337 (2005) 849-852
27. Ramadass P., Meerarani P., Toborek M., Robertson L.W., and Hennig B. Dietary flavonoids modulate PCB-induced oxidative stress, CYP1A1 induction, and AhR-DNA binding activity in vascular endothelial cells. Toxicol. Sci. 76 (2003) 212-219
28. Schlezinger J.J., Struntz W.D., Goldstone J.V., and Stegeman J.J. Uncoupling of cytochrome P450 1A and stimulation of reactive oxygen species production by co-planar polychlorinated biphenyl congeners. Aquat. Toxicol. 77 (2006) 422-432
29. Gustavsson P., and Hogstedt C. A cohort study of Swedish capacitor manufacturing workers exposed to polychlorinated biphenyls (PCBs). Am. J. Ind. Med. 32 (1997) 234-239
30. Hay A., and Tarrel J. Mortality of power workers exposed to phenoxy herbicides and polychlorinated biphenyls in waste transformer oil. Ann. N.Y. Acad. Sci. 837 (1997) 138-156
31. Matsumura F. On the significance of the role of cellular stress response reactions in the toxic actions of dioxin. Biochem. Pharmacol. 66 (2003) 527-540
32. Schwencke C., Braun-Dullaeus R.C., Wunderlich C., and Strasser R.H. Caveolae and caveolin in transmembrane signaling: implications for human disease. Cardiovasc. Res. 70 (2006) 42-49
33. Mineo C., and Shaul P.W. Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae. Cardiovasc. Res. 70 (2006) 31-41
34. Stan R.V. Structure of caveolae. Biochim. Biophys. Acta 1746 (2005) 334-348
35. Minshall R.D., and Malik A.B. Transport across the endothelium: regulation of endothelial permeability. Handb. Exp. Pharmacol. (2006) 107-144
36. Whitlock Jr. J.P. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 103-125
37. Lim E.J., Smart E.J., Toborek M., and Hennig B. The role of caveolin-1 in PCB77-induced eNOS phosphorylation in human-derived endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H3340-H3347
38. Oesterling E., Toborek M., and Hennig B. Benzo[a]pyrene induces intercellular adhesion molecule-1 through a caveolae and aryl hydrocarbon receptor mediated pathway. Toxicol. Appl. Pharmacol. (2008)
39. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., Menne J., Lindschau C., Mende F., Luft F.C., Schedl A., Haller H., and Kurzchalia T.V. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293 (2001) 2449-2452
40. Fielding C.J., and Fielding P.E. Relationship between cholesterol trafficking and signaling in rafts and caveolae. Biochim. Biophys. Acta 1610 (2003) 219-228
41. Le Lay S., and Kurzchalia T.V. Getting rid of caveolins: phenotypes of caveolin-deficient animals. Biochim. Biophys. Acta 1746 (2005) 322-333
42. Aoki T., Nomura R., and Fujimoto T. Tyrosine phosphorylation of caveolin-1 in the endothelium. Exp. Cell Res. 253 (1999) 629-636
43. Callera G.E., Montezano A.C., Yogi A., Tostes R.C., and Touyz R.M. Vascular signaling through cholesterol-rich domains: implications in hypertension. Curr. Opin Nephrol. Hypertens. 16 (2007) 90-104
44. Razandi M., Oh P., Pedram A., Schnitzer J., and Levin E.R. ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol. Endocrinol. 16 (2002) 100-115
45. Kiss A.L., Turi A., Mullner N., Kovacs E., Botos E., and Greger A. Oestrogen-mediated tyrosine phosphorylation of caveolin-1 and its effect on the oestrogen receptor localisation: an in vivo study. Mol. Cell Endocrinol. 245 (2005) 128-137
46. Lu M.L., Schneider M.C., Zheng Y., Zhang X., and Richie J.P. Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J. Biol. Chem. 276 (2001) 13442-13451
47. Schlegel A., Wang C., Katzenellenbogen B.S., Pestell R.G., and Lisanti M.P. Caveolin-1 potentiates estrogen receptor alpha (ERalpha) signaling. Caveolin-1 drives ligand-independent nuclear translocation and activation of ERalpha. J. Biol. Chem. 274 (1999) 33551-33556